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Introduction: Reduction in skeletal muscle regeneration capacity, such as in inflammatory muscle diseases and aging, leads 
to progressive muscle strength decrement, which impairs mobility and increases risk of falls and mortality, with a negative 
impact of quality of life. This reduction in skeletal muscle regeneration has been associated with an impaired function of 
the skeletal muscle stem cells, namely, the satellite cells. These cells are localized beneath basal lamina in a quiescence 
state and can be activated and differentiated into new myofibers after muscle damage. Indeed, satellite cells need to exit 
the cell cycle for differentiation. Therefore, the search for biological tools that can improve activation/differentiation of 
satellite cells is of great interest to regenerative medicine. In this regard, butyrate, a gut microbial metabolite, which can 
induce cell cycle arrest through histone deacetylase inhibition, has emerged as a therapeutic tool in some diseases, such 
as cancer. Then, we hypothesize that butyrate could improve skeletal muscle regeneration by accelerating satellite cells 
differentiation into myofibers through epigenetics mechanisms related to cell cycle exit. 
Objectives: To assess whether butyrate could improve skeletal muscle regeneration after barium chloride damage and its 
epigenetics mechanisms. 
Methods: Twenty C57Bl/6 male mice (CEUA: 133/2014), with 8 weeks of age, were grouped as follows: (1) control 
group with no injury + saline (C-Sal); (2) control group with no injury + butyrate (CBut); (3) injury with saline (I-Sal); 
and (4) injury + butyrate (I-But). The muscle injury was performed with the injection of 50 µL of barium chloride (1.2%) 
in both tibialis anterior and the muscles were harvested six and twelve days after injury for histological and molecular 
analyses. Butyrate were injected intraperitoneally (400 mg/kg) for 6 days. For in vitro assays, primary satellite cells were 
isolated and cultured as myoblasts. Myoblasts were treated with 300 µM of butyrate during proliferation and differentiation 
conditions in order to assess cell cycle molecules, differentiation index, and epigenetics mechanisms. The significance 
was assumed when P < 0.05. 
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Results: Skeletal muscle regeneration, assessed by cross-sectional area of tibialis anterior muscle, was higher in I-But 
than I-Sal group (P < 0.05). Histogram analysis also showed higher frequency of smaller fibers in I-Sal than I-But group 
(P < 0.05). In vitro analyses showed a reduction in the myoblasts proliferation when treated with butyrate (P < 0.05). Also, 
butyrate treatment downregulated genes related to cell cycle activation (cdk1, cdk2, cdk4), and up-regulated genes related 
to cell cycle repression (p57) (P < 0.05). The myotubes differentiation, assessed by fusion index, were higher in myoblasts 
treated with butyrate (P < 0.05), which was followed by an upregulation of the myogenic marker of differentiation, myogenin 
(P < 0.05). Moreover, butyrate was able to decrease histone deacetylase (P < 0.05) and increase histone acetyltransferase 
enzymatic activities (P < 0.05). 
Conclusion and discussion: Butyrate increased skeletal muscle regeneration in mice by accelerating the myotubes 
differentiation through induction of cell cycle arrest in myoblasts. Preliminary data suggested that this improvement was 
epigenetically mediated.
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